Gruber Lennart Johannes, Bühler Matthias Maximilian, Spillner Antonie, Andreas Stefan, Kauffmann Philipp, Schliephake Henning, Wolfer Susanne
Department of Oral and Maxillofacial Surgery, University Medical Center Goettingen, Goettingen, Germany.
Department of Cardiology and Pneumology, University Medical Center Goettingen, Goettingen, Germany.
Clin Exp Dent Res. 2025 Aug;11(4):e70154. doi: 10.1002/cre2.70154.
Tobacco smoking is one major risk factor in the development of oral squamous cell carcinoma (OSCC). Continuation of smoking after diagnosis and treatment is associated with an increase in recurrence rate and incidence of second tumors, with a shorter lon g-term survival and poorer response to therapy. In the current German guideline for the treatment of OSCC, there is no clear recommendation to participate in structured smoking cessation programs.
A total of 202 patients with histologically confirmed OSCC completed a one-time assessment of their smoking behavior using three standardized questionnaires during regular tumor follow-up. In addition to sociodemographic data, patients were asked retrospectively about their smoking habits and motivation to quit smoking before and after diagnosis and treatment.
A serious smoking cessation attempt before diagnosis of OSCC were stated in 54.8% of the participants. This number increased up to 82.2% after OSCC diagnosis. However, only 48.5% managed to quit smoking after diagnosis. Professional support was with only 21.92% (n = 16) rarely used. Motivation to quit was significantly lower before (2.75 ± 2.41) than after OSCC diagnosis (7.27 ± 2.41) (p = 0.001) and significantly higher among the participants who finally managed to quit (9.38 ± 1.68) than among those who continued smoking (4.79 ± 3.43) (p = 0.001).
The diagnosis of OSCC appears to be an important teachable moment for smoking cessation. To maximize this effect, an early and standardized implementation of systematic smoking cessation programs into the therapeutic concept of patients with OSCC is strongly recommended.
吸烟是口腔鳞状细胞癌(OSCC)发生的主要危险因素之一。诊断和治疗后继续吸烟与复发率增加、第二肿瘤发生率增加、长期生存率降低以及对治疗反应较差有关。在当前德国OSCC治疗指南中,对于参加结构化戒烟项目没有明确建议。
总共202例经组织学确诊的OSCC患者在定期肿瘤随访期间使用三份标准化问卷完成了对其吸烟行为的一次性评估。除社会人口统计学数据外,还回顾性询问了患者在诊断和治疗前后的吸烟习惯及戒烟动机。
54.8%的参与者表示在OSCC诊断前曾认真尝试戒烟。OSCC诊断后这一比例增至82.2%。然而,诊断后只有48.5%的人成功戒烟。专业支持仅21.92%(n = 16)被很少使用。戒烟动机在诊断前(2.75 ± 2.41)显著低于OSCC诊断后(7.27 ± 2.41)(p = 0.001),并且最终成功戒烟的参与者(9.38 ± 1.68)的戒烟动机显著高于继续吸烟者(4.79 ± 3.43)(p = 0.001)。
OSCC的诊断似乎是戒烟的一个重要契机。为了最大化这一效果,强烈建议在OSCC患者的治疗理念中尽早并标准化地实施系统性戒烟项目。